The development of this abnormal response to CM is one of the early changes associated with F-MuLV-induced leukemia.
Friend murine leukemia virus (F-MuLV) is a helper-independent, type C retrovirus that does not possess an oncogene (1, 2) . Newborn NFS/n mice inoculated with F-MuLV rapidly develop erythroleukemia and uniformly die within 8-14 wks. Despite the virulence of F-MuLV disease, leukemia cells obtained from these animals cannot be transplanted into syngeneic mice or explanted into tissue culture. However, if diseased animals are given transfusions of erythrocytes, transplantable leukemia cells can be isolated (3) . This functional distinction between transplantable and nontransplantable leukemia cells is used to divide F-MuLV disease into two stages. Stage I disease is characterized by massive hepatosplenomegaly, circulating erythroblasts, and severe anemia. However, the leukemia cells in stage I are not transplantable or explantable. Stage II disease is pathologically and histologically indistinguishable from stage I, but stage II leukemia cells can be transplanted or explanted. The histologic, virologic, and tissue culture characteristics of stage II leukemia cells have been described (3) . We wished to examine stage I leukemia cells since these cells appear to be the clinically important cell population in untreated F-MuLV disease.
In an attempt to propagate stage I cells in culture, we explanted the spleens and bone marrow of mice with stage I disease in the presence of WEHI-3 cell-conditioned medium (CM) (4); 100% of these explants gave rise to immortal cell lines that are dependent on CM for cell proliferation.
MATERIALS AND METHODS
Animals. NFS/n mice were originally obtained from the small animal facility at the National Institutes of Health (Bethesda, MD). Subsequently, mice were propagated by brother/sister matings in our own laboratory. Immunoprecipitation analysis of viral proteins (5) and blot hybridization analysis of cellular RNAs (6) were performed as described.
RESULTS
Newborn (<24 hr old) NFS/n mice were inoculated with 5 x 105 plaque-forming units of F-MuLV. After 6 weeks all of the mice were judged to have leukemia based on microscopic examination of their peripheral blood smears. Mice were then selected at random and sacrificed to obtain their spleens and bone marrow for explanting into tissue culture (Table 1) . Explants were performed weekly beginning 6 weeks after inoculation and continued for 4 weeks. Eighteen cell lines were established from the spleens and bone marrow of mice with stage I disease ( Table 1 ). All of the FMuLV-infected mice tested yielded continuous cell lines. Using the same culture conditions, we were unable to obtain cell lines from normal adult or newborn mice. Some initial growth did occur in cultures of uninfected hematopoietic cells. But these cultures died out within 2-3 weeks.
F-MuLV disease is associated with increased numbers of hematopoietic precursors in the spleen and bone marrow (7, 8) . Therefore, it is possible that the ability to establish cell lines from stage I mice is due to the large number of early hematopoietic cells in these animals rather than the presence of transformed cells. To test this hypothesis, we attempted to establish cell lines from uninfected mice that were treated with phenylhydrazine to expand their pool of hematopoietic precursors. Normal adult mice were injected intraperitonealAbbreviations: MuLV, murine leukemia virus; F-MuLV, Friend MuLV; CM, W3HI-3 cell-conditioned medium; F-MCFV, Friend mink cell focus-inducing virus; gp, glycoprotein.
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. ly with 2.0 mg of phenylhydrazine every 3-4 days for 3 weeks. Mice subjected to this regimen became anemic (hematocrits of 20-30%). After 2-3 injections, the mice developed extramedullary hematopoiesis in the spleen, and spleen weights increased 10-to 12-fold (Fig. 1) ; 80-90% of the nucleated cells in these spleens were immature erythroid precursors. This massive increase in erythropoiesis parallels the pathologic and histologic findings of stage I disease in FMuLV-infected mice. However, despite the increase in immature cells that occurred with repeated injections of phenylhydrazine, no continuous cell lines were established from the spleens or bone marrows of these mice ( Table 1) .
All of the cell lines derived from mice with stage I disease required WEHI-3 CM to proliferate in culture. When the cells were washed and resuspended in fresh media without WEHI-3 CM, the cells died within 96 hr. After 9 months in culture and 76 cell passages (see Table 1 ), this dependence on WEHI-3 CM for cell proliferation remained unchanged. WEHI-3 CM contains several hematopoietic growth factors (9, 10) . It is unclear which of these factors is (are) responsible for sustaining stage I cell lines in culture. Purified interleukin 3 extracted from WEHI-3 CM (11) (generously supplied by James Ihle) was able to substitute for WEHI-3 CM in supporting the growth of our CM-dependent cell lines (see below). Two cell lines (10-3 and BS-2) were selected for further analysis. 10-3 and BS-2 were normally maintained in culture by using Dulbecco's modified Eagle's medium containing 10% fetal calf serum and 10% WEHI-3 CM. Under these conditions, 10-2 and BS-2 cells doubled every 24 hr and reached a maximum cell density of 8-10 x 105 cells per ml. Identical growth kinetics were achieved by using as little as 50 units of purified interleukin 3 per ml in place of WEHI-3 CM. The growth potential of IO-3 and BS-2 also was tested in vivo. Cells (1 x 106) from each culture were inoculated into adult NFS/n mice; 4 weeks later representative animals were sacrificed and autopsied. No evidence of the 10-3 or BS-2 cells was detected. The remaining mice showed no signs of leukemia 8 months later.
10-3 and BS-2 cells produced high titers of retrovirus as measured by reverse transcriptase and XC plaque assays (12, 13) (data not shown). Both NIH 3T3 cells and mink lung cells could be infected with culture fluid obtained from these cell lines. The viruses most likely made by 10-3 and BS-2 were F-MuLV and Friend mink cell focus-inducing virus (F-MCFV), since both of these viruses are present in the hematopoietic tissues of F-MuLV-diseased mice (14, 15) . To verify the existence of both ecotropic (F-MuLV) and dualtropic (F-MCFV) virus in 10-3, we performed an immunoprecipitation analysis (5) (Fig. 2) focus-forming virus. These results suggest that the two faster migrating species are cleavage fragments of the envelope protein.
We next examined the state of oncogene expression in 10-3 cells by blot hybridization gel analysis (17) . Poly(A)-selected RNA was prepared from 10-3 (6). The RNA was run on agarose gels, transfered to nitrocellulose, and probed for the presence of messenger RNAs related to the following viral oncogenes: src, myb, myc, erbA, erbB, abl, fes, fems, mos, Ha-ras, Ki-ras, and sis. v-Ki-ras of the Kirsten sarcoma virus was expressed in IO-3 cells at higher levels than in normal bone marrow (Fig. 3) . No transcripts homologous to the remaining oncogenes were found (data not shown). Ki-ras was also the only oncogene identified in poly(A)-selected RNA prepared from leukemia cells of mice with stage I disease.
On microscopic examination, 10-3 and BS-2 cells were 95% immature blasts that contained peroxidase-positive granules. Of the cells, 1-5% were more mature myeloid elements, including myelocytes, metamyelocytes, and occasional mature granulocytes. 10-3 and BS-2 exhibited a density dependence of 1000 cells per ml of culture fluid for cell growth. We have not been able to develop single-cell clones of IO-3 or BS-2 by dilution cloning. However, IO-3 and BS-2 did form colonies derived from single cells in soft agar containing CM. These colonies also were composed of myeloblasts and maturing myeloid elements. vestigators have found that F-MuLV can induce myeloid as well as erythroid leukemias (21, 22) . It is possible that both transformed myeloid and erythroid precusors exist in FMuLV-infected mice, but our culture conditions favor the outgrowth of myeloid cells. Alternate culture conditions (23) may be needed to grow erythroid cell lines from F-MuLVinduced leukemias.
The exact relationship between CM-dependent cell lines and virally induced leukemia is unclear. 10-3 and BS-2 exhibit immortal or "transformed" cell growth in response to CM. However, these cells are not fully malignant because they do not cause leukemia when inoculated into syngeneic mice. Instead, CM-dependent cells may represent an early step in the multistage process of leukemogenesis. The fact that these cells require WEHI-3 CM or purified interleukin 3 for growth and survival implies that hematopoietic growth factors are needed to maintain some populations of transformed cells.
